35 reports

  • Top 10 pharmaceutical Companies: Revenue
  • Top 10 pharmaceutical Companies: Shionogi

Pharmaceuticals - Asia-Pacific Industry Leaders: Top 10 Company Financials Chartbooks Summary In recent years technological innovation has revolutionized almost all markets and industries. This combined with growing political uncertainty, slumps in consumer demand and shifting growth rates in developing economies has...

  • Pharmaceutical
  • APAC
  • Alfresa Group
  • Astellas Pharma Inc.
  • Shionogi & Co., Ltd.

Current Pharmaceutical Design; ##(##):##-##.

  • Artificial Intelligence
  • Healthcare
  • Information Technology
  • Pharmaceutical
  • Shionogi & Co., Ltd.
  • Cancer Supportive Care Market, Global, Cluster by Growth and Market Share, 2015-
  • Cancer Supportive Care Market, Global, Company Analysis Matrix, 2015-2022

Spectrum Pharmaceuticals.

  • Blood Disease
  • Cancer
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.
  • 8.1 References
  • 4.6.9 Conclusion

Of the top ## pharma companies, ## have at least one marketed pain therapeutics product, and this is expected to expand to ## by 2023.

  • Pain Relief
  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Shionogi & Co., Ltd.
  • latanoprostene bunod
  • Ophthalmology Therapeutics Market, Global, Forecast Revenues by Company, 2016-2023

The Pharma Innovation; ##(##): ##-## Bresnick GH (1983).

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.
  • Pharmaceuticals
  • NOVEN PHARMACEUTICALS

The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides...

  • Pharmaceutical
  • AbbVie Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Shionogi & Co., Ltd.
  • HEALTHCARE-ASSOCIATED INFECTIONS BY GRAM-NEGATIVE BACTERIA: KEY METRICS IN THE SEVEN
  • 10.1 OVERVIEW

PLOS ONE; ##(##): ##-##.

  • Pharmaceutical
  • United States
  • Company
  • Demand
  • Shionogi & Co., Ltd.
  • Pfizer
  • Vendor landscape

About Post-Menopausal Vaginal Atrophy Drugs Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects...

  • Pharmaceutical
  • Allergan plc
  • Novo Nordisk Group
  • Pfizer Inc.
  • Shionogi & Co., Ltd.

The readout of one of the most watched trials of Merck & Co. '

  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.
  • Shionogi & Co., Ltd.
  • SEPSIS AND SEPTIC SHOCK: KEY METRICS IN THE SEVEN MAJOR PHARMACEUTICAL MARKETS
  • COMMERCIAL BENCHMARK OF KEY INFECTION CONTROL TREATMENT OPTIONS - SEPSIS AND SEPTIC

OpportunityAnalyzer: Sepsis and Septic Shock - Opportunity Analysis and Forecasts to 2026 Summary Sepsis is a complex disease, which not only involves a wide array of causative agents, but also results in different individual immune responses causing various single or multiple organ dysfunction(s). In late 2016, the...

  • Blood Disease
  • Hospital
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • OIC - LATE-STAGE PIPELINE, 2015
  • Executive Summary

Pain; ##: ##-##.

  • Pharmaceutical
  • Southern Europe
  • United States
  • Demand
  • Shionogi & Co., Ltd.
  • SHIONOGI & CO LTD, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • SHIONOGI & CO LTD, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS

Summary Shionogi & Co Ltd, (Shionogi) is a healthcare company that focuses on the research, development, manufacturing, and marketing of pharmaceutical products, diagnostic reagents and medical devices.The company’s core pharmaceuticals product business consists of three categories, namely, Prescription Drugs, OTC Drugs...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Japan
  • Shionogi & Co., Ltd.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • PRAGMA PHARMA ACQUIRES KEFLEX FROM SHIONOGI
  • CONCORDIA PHARMA AND SHIONOGI ENTER INTO LICENSING AGREEMENT FOR ULESFIA

Summary Shionogi Inc (Shionogi), formerly Sciele Pharma, Inc., is a pharmaceutical company. It undertakes the development and commercialization of pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets products for...

  • Healthcare
  • Pharmaceutical
  • United States
  • Shionogi & Co., Ltd.
  • FUNPEP CO LTD, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • FUNPEP CO LTD, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS

Summary FunPep Co Ltd (FunPep) is a biotechnology venture company that develops functional peptides.The company uses smart peptide research integrated technology for developing functional peptides and search technology of epitope for unique peptide vaccine for developing antibody-inducing peptides. Its pipeline product...

  • Pharmaceutical
  • Japan
  • Company
  • Deals & Alliance
  • Shionogi & Co., Ltd.
  • LATE-STAGE PIPELINE FOR AR, 2014
  • 7 Pipeline Assessment

THE INCREASING IMMIGRATION IS ONE OF THE REASONS FOR THE INCREASE IN THE DEMAND FOR PHARMACEUTICALS (GLOBALDATA, 2013E).

  • Allergy Drug
  • Pharmaceutical
  • Therapy
  • Market Size
  • Shionogi & Co., Ltd.
  • LATE-STAGE PIPELINE FOR AR, 2014
  • 7 Pipeline Assessment

ALLERGY; ##(##): ##-##.

  • Allergy Drug
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.
  • Shionogi & Co., Ltd.
  • LATE-STAGE PIPELINE FOR AR, 2014
  • 7 Pipeline Assessment

ALLERGY; ##(##): ##-##.

  • Allergy Drug
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.
  • Shionogi & Co., Ltd.
  • Valuation multiples (C&O Pharmaceutical Technology (Holdings) Limited)
  • PRIVATE EQUITY AND OWNERSHIP - DEAL REPORTS

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' C&O Pharmaceutical...

  • Pharmaceutical
  • China
  • M&A
  • Shionogi & Co., Ltd.
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • SHIONOGI INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2011 TO YTD 2017

Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report...

  • Pharmaceutical
  • United States
  • Company
  • M&A
  • Shionogi & Co., Ltd.
  • Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017

Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats....

  • Healthcare
  • Pharmaceutical
  • Japan
  • Company Financials
  • Shionogi & Co., Ltd.
  • CLINICAL AND COMMERCIAL ATTRACTIVENESS
  • MECHANICAL VENTILATION IS RARELY USED IN THE UK

One such competitor is Aerodone, an inhalable formulation of pirfenidone in preclinical development by Genoa Pharmaceuticals.

  • Pharmaceutical
  • Therapy
  • East Asia
  • Boehringer Ingelheim GmbH
  • Shionogi & Co., Ltd.
  • OF CONTENTS
  • PARTNERSHIP - DEAL REPORTS

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' LifeCycle...

  • Pharmaceutical
  • United States
  • Company Financials
  • Deals & Alliance
  • Shionogi & Co., Ltd.
  • PARTNER 2: SCIELE PHARMA, INC.
  • PARTNER 2: LIFECYCLE PHARMA A/S

Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A),...

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.
  • Valuation multiples (Sciele Pharma, Inc.)
  • PARTNER 2: LIFECYCLE PHARMA A/S

Shionogi & Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A),...

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Shionogi & Co., Ltd.
  • Sales Comparisons (Most Recent Fiscal Year)
  • Summary of company valuations (as of 5/25/2018).

Ltd. is a Japan-based pharmaceutical company, mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses.

  • Pharmaceutical
  • Japan
  • Company Financials
  • Shionogi & Co., Ltd.
  • SHIONOGI & CO., LTD.: KEY COMPETITORS
  • SHIONOGI & CO., LTD.: MANAGEMENT STATEMENT

Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions,...

  • Pharmaceutical
  • Therapy
  • Japan
  • Company
  • Shionogi & Co., Ltd.